BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31515910)

  • 1. Fractionation in adjuvant radiotherapy for invasive breast cancer and ductal carcinoma in situ in Ontario, Canada from 2009 to 2015.
    Chan S; Sutradhar R; Yao Z; Chow E; Lee J; Wan BA; Paszat L
    Breast J; 2020 Apr; 26(4):602-616. PubMed ID: 31515910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast.
    Lalani N; Paszat L; Sutradhar R; Thiruchelvam D; Nofech-Mozes S; Hanna W; Slodkowska E; Done SJ; Miller N; Youngson B; Tuck A; Sengupta S; Elavathil L; Chang MC; Jani PA; Bonin M; Rakovitch E
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1017-24. PubMed ID: 25220719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
    De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Adjuvant Breast Hypofractionation Radiation Treatment at a Cancer Center in Ontario From 2011 to 2018.
    Lam E; Chan S; Karam I; Lee J; Wong G; Zhang L; Vesprini D; Wronski M; Chin L; Razvi Y; McKenzie E; Rakovitch E; Chow E
    Clin Breast Cancer; 2020 Oct; 20(5):e612-e617. PubMed ID: 32321680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.
    Punglia RS; Cronin AM; Uno H; Stout NK; Ozanne EM; Greenberg CC; Frank ES; Schrag D
    JAMA Oncol; 2017 Jan; 3(1):101-104. PubMed ID: 27442038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local treatment options for young women with ductal carcinoma in situ: A systematic review and meta-analysis comparing breast conserving surgery with or without adjuvant radiotherapy, and mastectomy.
    Chien JC; Liu WS; Huang WT; Shih LC; Liu WC; Chen YC; Chou KJ; Shiue YL; Lin PC
    Breast; 2022 Jun; 63():29-36. PubMed ID: 35299032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.
    Rakovitch E; Nofech-Mozes S; Narod SA; Hanna W; Thiruchelvam D; Saskin R; Taylor C; Tuck A; Sengupta S; Elavathil L; Jani PA; Done SJ; Miller N; Youngson B; Kong I; Paszat L
    Breast Cancer Res Treat; 2013 Apr; 138(2):581-90. PubMed ID: 23456231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receipt of mastectomy and adjuvant radiotherapy following breast conserving surgery (BCS) in New Zealand women with BCS-eligible breast cancer, 2010-2015: an observational study focusing on ethnic differences.
    Bartholomew K; Ghafel M; Tin Tin S; Aye PS; Elwood JM; Hardie C; Scott N; Kidd J; Ramsaroop R; Campbell I
    BMC Cancer; 2023 Aug; 23(1):766. PubMed ID: 37592208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated radiation therapy for breast ductal carcinoma in situ.
    Hathout L; Hijal T; Théberge V; Fortin B; Vulpe H; Hogue JC; Lambert C; Bahig H; Provencher L; Vavassis P; Yassa M
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1058-63. PubMed ID: 24113057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy.
    Giannakeas V; Sopik V; Narod SA
    JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of boost radiation in the treatment of ductal carcinoma in situ: a population-based analysis.
    Rakovitch E; Narod SA; Nofech-Moses S; Hanna W; Thiruchelvam D; Saskin R; Taylor C; Tuck A; Youngson B; Miller N; Done SJ; Sengupta S; Elavathil L; Jani PA; Bonin M; Metcalfe S; Paszat L
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):491-7. PubMed ID: 23708085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.
    Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Gu S; Fong C; Tuck A; Youngson B; Miller N; Done SJ; Chang MC; Sengupta S; Elavathil L; Jani PA; Bonin M; Lalani N; Paszat L
    Breast; 2018 Feb; 37():181-186. PubMed ID: 28781102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy.
    Pawloski KR; Tadros AB; Sevilimedu V; Newman A; Gentile L; Zabor EC; Morrow M; Van Zee KJ; Kirstein LJ
    Breast Cancer Res Treat; 2021 Apr; 186(3):617-624. PubMed ID: 33675490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing use of post-mastectomy hypofractionated radiation therapy for breast cancer in Victoria.
    Kim S; Pitson G; Koh TL; Chao M; Byrne K; Hornby C; Foroudi F; Millar J; Ong WL
    J Med Imaging Radiat Oncol; 2022 Apr; 66(3):428-435. PubMed ID: 34811941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? Yes. Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast.
    Buchholz TA; Haffty BG; Harris JR
    J Surg Oncol; 2007 Jun; 95(8):610-3. PubMed ID: 17221862
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of radiation after breast conserving surgery (BCS) for DCIS and early invasive breast cancer at Charleston Area Medical Center (CAMC). A study of compliance with National Comprehensive Cancer Network (NCCN) guidelines.
    Dean CT; Jubelirer SJ; Plants BA; Welch CA
    W V Med J; 2009 Oct; 105 Spec No():34-8; quiz 39. PubMed ID: 19999263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionation Is an Acceptable Alternative to Conventional Fractionation in the Treatment of Postlumpectomy Ductal Carcinoma In Situ With Radiotherapy.
    Isfahanian N; Al-Hajri T; Marginean H; Chang L; Caudrelier JM
    Clin Breast Cancer; 2017 Apr; 17(2):e77-e85. PubMed ID: 27889437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective use of whole breast radiotherapy after breast conserving surgery for invasive breast cancer and DCIS.
    Skandarajah AR; Bruce Mann G
    Surgeon; 2013 Oct; 11(5):278-85. PubMed ID: 23632044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative retrospective analysis of locoregional recurrence in unselected breast cancer patients treated with conventional versus hypofractionated radiotherapy at a tertiary cancer center?
    Yadav R; Lal P; Agarwal S; Misra S; Verma M; Das KJM; Senthil Kumar SK; Kumar A; Mishra SK; Agarwal A; Agarwal G; Mishra A; Chand G; Verma AK; Kumar S
    J Cancer Res Ther; 2020; 16(6):1314-1322. PubMed ID: 33342790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.